Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized study of two interferon-beta treatments in relapsing-remitting multiple sclerosis.
Koch-Henriksen N, Sørensen PS, Christensen T, Frederiksen J, Ravnborg M, Jensen K, Heltberg A, Kristensen O, Stenager E, Petersen T, Hansen T; Danish Multiple Sclerosis Group. Koch-Henriksen N, et al. Among authors: frederiksen j. Neurology. 2006 Apr 11;66(7):1056-60. doi: 10.1212/01.wnl.0000204018.52311.ec. Epub 2006 Mar 1. Neurology. 2006. PMID: 16510769 Clinical Trial.
Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis.
Sorensen PS, Ross C, Clemmesen KM, Bendtzen K, Frederiksen JL, Jensen K, Kristensen O, Petersen T, Rasmussen S, Ravnborg M, Stenager E, Koch-Henriksen N; Danish Multiple Sclerosis Study Group. Sorensen PS, et al. Lancet. 2003 Oct 11;362(9391):1184-91. doi: 10.1016/S0140-6736(03)14541-2. Lancet. 2003. PMID: 14568740 Clinical Trial.
Antibodies to IFN-beta: the Danish National IFN-beta Project.
Sorensen PS, Ross C, Clemmesen KM, Bendtzen K, Frederiksen JL, Jensen K, Kristensen O, Petersen T, Rasmussen S, Ravnborg M, Stenager E, Koch-Henriksen N; Danish Multiple Sclerosis Study Group; Danish Interferon-beta Project. Sorensen PS, et al. Neurology. 2003 Nov 11;61(9 Suppl 5):S27-8. doi: 10.1212/01.wnl.0000092362.44313.b6. Neurology. 2003. PMID: 14610108 Clinical Trial. No abstract available.
[Clinical importance of neutralising antibodies against interferon-beta in patients with relapsing-remitting multiple sclerosis].
Sørensen S, Koch-Henriksen NJ, Pedersen CR, Clemmesen KM, Bendtzen K, Frederiksen JL, Jensen K, Kristensen O, Petersen T, Rasmussen S, Ravnborg M, Stenager E; Dansk Multipel Sklerose Gruppe. Sørensen S, et al. Among authors: frederiksen jl. Ugeskr Laeger. 2004 Oct 4;166(41):3606-9. Ugeskr Laeger. 2004. PMID: 15515467 Danish. No abstract available.
385 results